Organization · Venture Capital
Braavos Investment Advisers
Braavos Investment Advisers is a London-based venture capital firm specializing in investments in companies founded on scientific breakthroughs, particularly those linked to Oxford's research ecosystem.
Overview
What Braavos Investment Advisers does
What Braavos Investment Advisers is
Braavos Investment Advisers is a London-based venture capital firm specializing in investments in companies founded on scientific breakthroughs, particularly those linked to Oxford's research ecosystem.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Braavos Investment Advisers elsewhere
Open the official website or a supported primary organization account.
Capability profile
Braavos Investment Advisers as a funder
Investment thesis
Braavos Investment Advisers backs companies founded on scientific breakthroughs, focusing on research-intensive businesses with technical differentiation and a credible path from research to commercial scale.
Focus narrative
Braavos Investment Advisers primarily invests in early-stage through growth companies that are rooted in scientific innovation. The firm seeks to identify opportunities in sectors such as quantum computing, synthetic biology, diagnostics, and AI infrastructure. By leveraging its expertise and network, Braavos aims to provide substantial support to portfolio companies, helping them navigate the complexities of bringing groundbreaking technologies to market.
Value beyond capital
Braavos Investment Advisers adds value to its portfolio companies by providing not only capital but also strategic guidance and access to a specialized network. The firm supports its companies through board-level involvement, helping them navigate technical and regulatory challenges while facilitating follow-on funding and partnerships. Braavos is particularly adept at assisting companies with long development timelines and substantial technical risks, ensuring they have the resources and expertise needed to succeed.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Sectors
- Biotech · Healthcare · AI · Climate · Energy · Quantum Computing · Diagnostics · Synthetic Biology
- Regions
- United KingdomEurope
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
OXCCU: Developing catalysts to convert waste carbon into sustainable aviation fuel; raised £20.75M in Series B. Salience Labs: Photonics company creating optical switches for AI datacenter infrastructure; raised $30M in Series A. Oxford Ionics: Trapped-ion quantum computing firm; raised £30M in Series A. Wild Bioscience: Synthetic biology company focused on climate-smart crops; raised £45M. SpyBiotech: Utilizing protein-superglue technology for vaccines; Andre Crawford-Brunt serves as Investor Director. PQShield: Specializing in post-quantum cryptography. Osler Diagnostics: Developing portable lab technology for diagnostics. First Light Fusion: Innovating in fusion energy technology. Charm Therapeutics: AI-driven drug discovery targeting molecular configurations. Living Optics: Focused on hyperspectral imaging technology.
Common questions
What to know about Braavos Investment Advisers
Upseed classifies Braavos Investment Advisers under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.